Gastrointestinal Bleeding in Small Intestinal Stromal Tumors: A Clinicopathological and Survival Analysis
Turkish Journal of Gastroenterology · 2025
DOI: 10.5152/tjg.2025.25205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, 2025. Verfasst von Fengqin Fu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Zhangzhou Municipal Hospital Affiliated to Fujian Medical University, Zhangzhou, China. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Gastrointestinal Hemorrhage, Intestinal Neoplasms, Intestine, Small. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background/Aims: This study analyzes the clinical pathological characteristics and prognostic factors of small intestinal stromal tumor (SIST) patients with gastrointestinal (GI) bleeding and investigates whether GI bleeding is an independent predictor of SIST prognosis. Materials and Methods: A retrospective analysis of 152 patients diagnosed with SISTs at Zhangzhou Municipal Hospital Affiliated to Fujian Medical University was conducted. Patients were divided into 2 groups based on the presence or absence of GI bleeding. Both survival and recurrence rates were calculated using univariate survival analysis and Cox regression analysis, respectively.
Results
Compared with the non-GI bleeding group, the GI bleeding group showed significant differences in tumor rupture and Ki-67 abundance (P < .05). Survival analysis revealed that patients with GI bleeding had a shorter relapse-free survival (RFS) compared to those without GI bleeding (P = .016); however, GI bleeding significantly impacted RFS only in the high-risk group (P = .001). Cox regres sion analysis showed that mitotic count (P = .021), tumor rupture (P = .032), Ki67 positivity (P = .032), and GI bleeding (P = .04) were independent factors affecting the relapse-free survival rate of SISTs.
Conclusion
This study shows that SIST patients with GI bleeding are more likely to experience tumor rupture and have higher Ki-67 positivity than those without GI bleeding. Mitotic count, tumor rupture, Ki-67 abundance, and GI bleeding are independent predictors of SIST prognosis. Additionally, the RFS rate for patients with GI bleeding is shorter, particularly among high-risk patients. Cite this article as: Fu FQ, Pu H, Huang WP, Han L, Deng YB, Lai YD. Gastrointestinal bleeding in small intestinal stromal tumors: A clinicopathological and survival analysis. Turk J Gastroenterol. Published online November 21, 2025. doi:10.5152/tjg.2025.25205.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Zhangzhou Municipal Hospital Affiliated to Fujian Medical University, Zhangzhou, China.
Zitieren
APA
Fu, F., Pu, H., Huang, W., Han, L., Deng, Y., & Lai, Y. (2025). Gastrointestinal Bleeding in Small Intestinal Stromal Tumors: A Clinicopathological and Survival Analysis. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2025.25205
Vancouver
Fu F, Pu H, Huang W, Han L, Deng Y, Lai Y. Gastrointestinal Bleeding in Small Intestinal Stromal Tumors: A Clinicopathological and Survival Analysis. Turkish Journal of Gastroenterology. 2025. doi:10.5152/tjg.2025.25205
BibTeX
@article{Fu2025,
author = {Fu, Fengqin and Pu, Hui and Huang, Weiping and Han, Lin and Deng, Yongbin and Lai, Yadong},
title = {Gastrointestinal Bleeding in Small Intestinal Stromal Tumors: A Clinicopathological and Survival Analysis},
journal = {Turkish Journal of Gastroenterology},
year = {2025},
doi = {10.5152/tjg.2025.25205}
}
EUVIMED